Cargando…
Countering opioid-induced respiratory depression by non-opioids that are respiratory stimulants
Strong opioid analgesics are the mainstay of therapy for the relief of moderate to severe acute nociceptive pain that may occur post-operatively or following major trauma, as well as for the management of chronic cancer-related pain. Opioid-related adverse effects include nausea and vomiting, sedati...
Autores principales: | Imam, Mohammad Zafar, Kuo, Andy, Smith, Maree T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008602/ https://www.ncbi.nlm.nih.gov/pubmed/32089833 http://dx.doi.org/10.12688/f1000research.21738.1 |
Ejemplares similares
-
Opioid-induced respiratory depression: reversal by non-opioid drugs
por: van der Schier, Rutger, et al.
Publicado: (2014) -
Pupillary unrest, opioid intensity, and the impact of environmental stimulation on respiratory depression
por: McKay, Rachel Eshima, et al.
Publicado: (2021) -
Risk of respiratory depression with opioids and concomitant gabapentinoids
por: Savelloni, Julie, et al.
Publicado: (2017) -
Genetic variation regulates opioid-induced respiratory depression in mice
por: Bubier, Jason A., et al.
Publicado: (2020) -
CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats
por: Imam, Mohammad Zafar, et al.
Publicado: (2023)